- Sodium sulfadiazine
-
-
2026-07-24
- CAS:547-32-0
- Min. Order: 25KG
- Purity: 99%-100.5%;USP
- Supply Ability: 5 tons
- Sodium sulfadiazine
-
- $20.00
-
2026-05-28
- CAS:547-32-0
- Min. Order: 10kg
- Purity: 99%
- Supply Ability: 10000kg
|
| | Sodium sulfadiazine Basic information |
| Product Name: | Sodium sulfadiazine | | Synonyms: | 4-AMINO-N-[2-PYRIMIDINYL]BENZENESULFONAMIDE SODIUM SALT;(n(sup1)-2-pyrimidinylsulfanilamido)-sodiu;2-sulfanilamidopyrimidinesodiumsalt;4-amino-n-2-pyrimidinyl-benzenesulfonamidmonosodiumsalt;monosodium2-sulfanilamidopyrimidine;n(sup1)-2-pyrimidinylsulfanilamidemonosodiumsalt;n(sup1)-2-pyrimidinyl-sulfanilamidmonosodiumsalt;n(sup1)-2-pyrimidinyl-sulfanilamidn(sup1)-sodiumderiv | | CAS: | 547-32-0 | | MF: | C10H11N4NaO2S | | MW: | 274.27 | | EINECS: | 208-919-0 | | Product Categories: | pharmaceutical;API;547-32-0 | | Mol File: | 547-32-0.mol |  |
| | Sodium sulfadiazine Chemical Properties |
| Melting point | >300°C | | storage temp. | Keep in dark place,Inert atmosphere,2-8°C | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | color | White to Off-White | | BRN | 4068213 | | Stability: | Hygroscopic | | Major Application | forensics and toxicology
pharmaceutical (small molecule) | | InChI | InChI=1S/C10H10N4O2S.Na.H/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10;;/h1-7H,11H2,(H,12,13,14);; | | InChIKey | JLDCNMJPBBKAHH-UHFFFAOYSA-N | | SMILES | S(C1C=CC(N)=CC=1)(=O)(=O)NC1=NC=CC=N1.[NaH] | | CAS DataBase Reference | 547-32-0(CAS DataBase Reference) |
| Hazard Codes | Xn | | Risk Statements | 22-36/37/38-42/43 | | Safety Statements | 22-26-36/37-45 | | RIDADR | 3249 | | WGK Germany | 3 | | RTECS | WP2000000 | | F | 10-21 | | HazardClass | 6.1(b) | | PackingGroup | III | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Oral
Aquatic Chronic 2
Eye Irrit. 2
Skin Irrit. 2 |
| | Sodium sulfadiazine Usage And Synthesis |
| Chemical Properties | White to yellow crystalline powder | | Uses | Sulfadiazine may be used as an internal standard for the determination of sulfapyridine in biological samples using high-performance liquid chromatography technique. | | Uses | Sulfadiazine Sodium Salt can be used as reactant/reagent in preparation and crystal structure of aminophenyl sulfonamide tetrahalides, hydrochloride and hydrobromide cocrystals with iodine. | | General Description | Soluble sulfadiazine is an anhydrous, white, colorless, crystallinepowder soluble in water (1:2) and slightly soluble inalcohol. Its water solutions are alkaline (pH 9–10) and absorbcarbon dioxide from the air, with precipitation of sulfadiazine.It is administered as a 5% solution in sterile waterintravenously for patients requiring an immediately highblood level of the sulfonamide. | | in vivo | In this study, the effectiveness of Sulfadiazine sodium and Pyrimetamine for the treatment of mice during acute infection with different atypical T. gondii strains was evaluated. Swiss mice were infected with seven T. gondii strainsl. The infected mice were treated with 10-640mg/kg per day of Sulfadiazine sodium, 3-200mg/kg per day of Pyrimetamine, or a combination of both drugs with a lower dosage. A descriptive analysis was used to assess the association between susceptibility to sodium and/or Pyrimetamine and the genotype. The TgCTBr4 and TgCTBr17 strains (genotype 108) presented lower susceptibility to sodium or Pyrimetamine treatment. The TgCTBr1 and TgCTBr25 strains (genotype 206) presented similar susceptibility to PYR but not sodium treatment. The TgCTBr9 strain (genotype 11) was the only strain with high susceptibility to treatment with both drugs [1]. | | IC 50 | Toxoplasma |
| | Sodium sulfadiazine Preparation Products And Raw materials |
|